- Abbott Suspends Diet Drug Sales After EMEA Request (PharmaTimes)
- Big Pharma Faces Tougher 2010 Despite US Boost (Reuters)
- SkyePharma Suffers as FDA Turns Down Flutiform NDA (PharmaTimes)
- Novartis Receives Japanese Approval For Three New Medicines (New Statesmen)
- GlaxoSmithKline, Genmab Get European Approval For Arzerra (The Wall Street Journal)
- Sanofi-aventis and Employees Unite for the Victims of Haiti (World Pharma News)
- Inspiration, Ipsen Try to Lock Up Hemophilia Market in $259M Deal (BioWorld)
- Pfizer/Auxilium’s Contracted Hand Drug set for EU Review (PharmaTimes)
- Teva Gets Tentative FDA OK for Generic Femara (AP)
- Pfizer: Kidney Drug Sutent Holds Off Pancreatic Cancer Spread (The Wall Street Journal)
- Reuters Examines Chronic Disease In Developing Countries, Future Of Drug Prices (Medical News Today)
SUBSCRIBE